Reporting owner · Q3 2026 · CIK 1858176

Kemble George: insider trades.

Kemble George reported 7 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($3.9M), across 1 company.

Transactions
7
Purchases (P)
0
Sales (S)
3
Companies
1
Name as filed
Kemble George

Companies

CompanyRelationshipTransactions
Sagimet Biosciences Inc. (SGMT)Director7

Transactions

7 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-14Sagimet Biosciences Inc.M326,618$6.36388,779Form 4
2026-08-14Sagimet Biosciences Inc.M24,369$6.36413,148Form 4
2026-08-14Sagimet Biosciences Inc.S350,987$10.2362,161Form 4
2026-08-11Sagimet Biosciences Inc.M9,751$6.3671,912Form 4
2026-08-11Sagimet Biosciences Inc.S20,206$9.9562,161Form 4
2026-08-11Sagimet Biosciences Inc.M10,455$6.3682,367Form 4
2026-07-20Sagimet Biosciences Inc.S18,844$7.4662,161Form 4

Questions

What stock did Kemble George buy or sell?

Kemble George reported 7 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($3.9M), across 1 company.

Is Kemble George the same person as other filers with this name?

This page covers SEC CIK 1858176 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/kemble-george-1858176.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.